BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, April 12, 2026
Home » Topics » Briefs » In the clinic

In the clinic
In the clinic RSS Feed RSS

In the clinic for Oct. 31, 2025

Oct. 31, 2025
Clinical updates, including data readouts and publications: Argenx, Avobis, Dianthus, Innocare, Johnson & Johnson, Neutrolis, Novartis, Tectonic, Unicycive, Vor, Wave.
Read More

In the clinic for Oct. 30, 2025

Oct. 30, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Humacyte, Recor Medical, Surmodics, Tactile Medical.
Read More

In the clinic for Oct. 30, 2025

Oct. 30, 2025
Clinical updates, including data readouts and publications: Abbvie, Anaptysbio, Bridgebio, Concerto, Eisai, Kyverna, Merck, Sonoma.
Read More

In the clinic for Oct. 29, 2025

Oct. 29, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Anteris, Fastwave, Philips, Sweetch Health, Theranica Bio-Electronics.
Read More

In the clinic for Oct. 29, 2025

Oct. 29, 2025
Clinical updates, including data readouts and publications: Aldeyra, Ardelyx, Ayrmid, Causeway, Cingulate, Delix, Edesa, Ferring, Lantern, Lumosa, Merck, Oncolytics, Quoin, Roche, Sudo, Trethera.
Read More

In the clinic for Oct. 28, 2025

Oct. 28, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cardiosense, Medtronic, Mercy Bioanalytics, Natera, Pleural Dynamics, Smith+Nephew.
Read More

In the clinic for Oct. 28, 2025

Oct. 28, 2025
Clinical updates, including data readouts and publications: BMS, Bridgebio, Cabaletta, Cristcot, Halda, Innovent, Intellia, ITM, Kyverna, J&J, Levicept, Sobi, Xencor, Zenas.
Read More

In the clinic for Oct. 28, 2025

Oct. 28, 2025
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Advancell Isotopes, Astellas, Entera Bio, Harbour Biomed, Iaso Biotherapeutics, Metis Techbio, Rapt Therapeutics, Sagimet Biosciences.
Read More

In the clinic for Oct. 27, 2025

Oct. 27, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cordis, Elixir, Exact, Jupiter, Medtronic, Penumbra, Quest.
Read More

In the clinic for Oct. 27, 2025

Oct. 27, 2025
Clinical updates, including data readouts and publications: Aprea, Arcutis, Armata, Ascletis, Dicot, Eli Lilly, Entera, George Medicines, Hanchorbio, Harbour, Incyte, Inhibrx, Johnson & Johnson, Journey Medical, Metis, Moderna, Revolution, Sagimet, Silver Creek, Spinogenix, Ventyx, Verastem, Zai Lab, Zymeworks.
Read More
Previous 1 2 … 14 15 16 17 18 19 20 21 22 … 320 321 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 10, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 7, 2026
  • MMP inhibitors divulged in Accure Therapeutics patent

    BioWorld Science
    Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
  • MSD discloses new HCN1/2 blockers

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
  • Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent

    BioWorld Science
    Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing